Healthcare
Live Price
Offline$2.92
-3.63% today
Window Change
-24.87%
Window
May 29, 2026 → Jun 18, 2026
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 15 bars · May 29, 2026 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Cabaletta Bio, Inc. (CABA) is a Healthcare stock with a market cap of $400.00M. The stock last traded around $2.92 and down 24.9% across the available one-year price window (May 29, 2026 → Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +29.9%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +29.9%, free cash flow -46.3% with operating margin 0.0% and ROIC -123.8%. Stock Foundry combines CABA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CABA
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CABA Max Drawdown
-25.93%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for CABA and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.